Authors:
Ruottinen, HM
Niinivirta, M
Bergman, J
Oikonen, V
Solin, O
Eskola, O
Eronen, E
Sonninen, P
Rinne, UK
Citation: Hm. Ruottinen et al., Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging, SYNAPSE, 40(1), 2001, pp. 19-26
Authors:
Francis, G
Hughes, R
King, J
Mitchell, P
Joubert, J
McLeod, J
Parker, G
Pollard, J
Sindic, CJM
Duprez, T
Medaer, R
Broeckx, J
Vanroose, E
Carton, H
Wilms, G
Rice, G
Ebers, G
Lee, DH
Freedman, M
Nelson, R
Rabinovitch, H
Christie, S
Avruch, L
Oger, J
Paty, DW
Li, D
Wikstrom, J
Salonen, OLM
Panelius, M
Eralinna, J
Sonninen, P
Rieckmann, P
Hahn, D
Flachenecker, P
Hartung, HP
Uitdehaag, B
Bertelsmann, FW
Barkhof, F
Hommes, OR
Jongen, PJH
Van Doorn, PA
Tanghe, HLG
Sandberg-Wollheim, M
Larsson, EM
Lonntoft, M
Sallerfors, S
Kappos, L
Lienert, C
Radu, EW
Chofflon, M
Roth, S
Castillo, V
Schwieger, AF
Hughes, RAC
Clews, AM
Bingham, JB
Barnes, D
Clifton, AG
Stoy, N
Bates, D
Coulthard, A
Blumhardt, LD
Evans, SM
Jaspan, T
Palace, J
Newsom-Davis, JM
Byrne, JV
Quaghebeur, G
Li, DKB
Paty, DW
Zhao, GJ
Riddehough, A
Rhodes, B
Citation: G. Francis et al., PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS, NEUROLOGY, 56(12), 2001, pp. 1628-1636
Authors:
Nuutinen, J
Sonninen, P
Lehikoinen, P
Sutinen, E
Valavaara, R
Eronen, E
Norrgard, S
Kulmala, J
Teras, M
Minn, H
Citation: J. Nuutinen et al., Radiotherapy treatment planning and long-term follow-up with [C-11]methionine pet in patients with low-grade astrocytoma, INT J RAD O, 48(1), 2000, pp. 43-52
Authors:
Nurmi, E
Bergman, J
Eskola, O
Solin, O
Hinkka, SM
Sonninen, P
Rinne, JO
Citation: E. Nurmi et al., Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study, J CEREBR B, 20(11), 2000, pp. 1604-1609
Authors:
Kauppila, M
Koskinen, P
Pulkki, K
Sonninen, P
Remes, K
Irjala, K
Viikari, J
Citation: M. Kauppila et al., Interferon-alpha treatment decreases serum crosslinked C-terminal telopeptide of type I collagen in haematological diseases, CLIN LAB H, 22(1), 2000, pp. 15-19
Authors:
Varho, T
Jaaskelainen, S
Tolonen, U
Sonninen, P
Vainionpaa, L
Aula, P
Sillanpaa, M
Citation: T. Varho et al., Central and peripheral nervous system dysfunction in the clinical variation of Salla disease, NEUROLOGY, 55(1), 2000, pp. 99-103
Authors:
Rinne, JO
Bergman, J
Ruottinen, H
Haaparanta, M
Eronen, E
Oikonen, V
Sonninen, P
Solin, O
Citation: Jo. Rinne et al., Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease, SYNAPSE, 31(2), 1999, pp. 119-124
Authors:
Nanto-Salonen, K
Koskinen, P
Sonninen, P
Toppari, J
Citation: K. Nanto-salonen et al., Suppression of GH secretion in pituitary gigantism by continuous subcutaneous octreotide infusion in a pubertal boy, ACT PAEDIAT, 88(1), 1999, pp. 29-33
Authors:
Saario, R
Sonninen, P
Mottonen, T
Viikari, J
Toivanen, A
Citation: R. Saario et al., Bone mineral density of the lumbar spine in patients with advanced rheumatoid arthritis - Influence of functional capacity and corticosteroid use, SC J RHEUM, 28(6), 1999, pp. 363-367
Authors:
Varho, T
Komu, M
Sonninen, P
Holopainen, I
Nyman, S
Manner, T
Sillanpaa, M
Aula, P
Lundbom, N
Citation: T. Varho et al., A new metabolite contributing to N-acetyl signal in H-1 MRS of the brain in Salla disease, NEUROLOGY, 52(8), 1999, pp. 1668-1672
Authors:
Rinne, JO
Ruottinen, H
Bergman, J
Haaparanta, M
Sonninen, P
Solin, O
Citation: Jo. Rinne et al., Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease, J NE NE PSY, 67(6), 1999, pp. 737-741